Merganser Biotech (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- February 19, 2015
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $28,000,000
Company Info
- Founding Year
- 2013
- Founders
- Brian MacDonald, Gene Merutka
- Company Description
- Merganser Biotech focuses on the evaluation of novel hepcidin mimetic peptides for the treatment of beta thalassemia and other rare hematological and iron overload diseases. The company obtained an exclusive worldwide license to patent rights for this technology from the Regents of the University of California in 2013.
- Market
- Hematological and iron overload diseases
- Location
- Newtown Square, PA, USA
- Coinvestors
- BioAdvance, Frazier Healthcare, Novartis Venture Funds, Osage University Partners, Stateside Developments, Sutter Hill Ventures